Dr. Chima D. Nwankwo, MD

Dr. Nwankwo practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Nwankwo's NPI, 1356772479, was assigned on November 30, 2013. Dr. Nwankwo graduated from University of California, San Francisco School of Medicine in 2013. Dr. Nwankwo holds New York license 300510.

Dr. Nwankwo's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Nwankwo's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Nwankwo to 2 more clinical labs, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nwankwo practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic trauma is Dr. Nwankwo's primary specialty in the NPI Registry, under taxonomy code 207XX0801X. Dmand AI has Dr. Nwankwo's licenses on file in 3 states: New York, California and Pennsylvania.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, hip replacement, joint pain, leg, ankle or foot fracture, minor injury to a limb and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Nwankwo treats.

CMS data shows 275 Medicare services from Dr. Nwankwo across 5 procedure codes in 2024, for 178 Medicare patients. Medicare paid $41,259 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. Nwankwo in 2024. The largest group is 75 to 84, with 65 patients. 75% of them have arthritis, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nwankwo's median patient age at 61, with 61% women.

In 2024, Dr. Nwankwo wrote 100 Medicare Part D claims for 42 patients. 100% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $322 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Nwankwo for performance year 2024, reported as part of a group. Dr. Nwankwo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Nwankwo, published from 2013 to 2024. 2016 was the busiest year, with 3. The most frequent topics are Arthroplasty, Replacement, Hip, Biomechanical Phenomena and Hip Prosthesis. Dr. Nwankwo has published most often in Arthroplast Today. Dr. Nwankwo's most frequent co-authors are Michael D. Ries, MD, Derek Fakhredean Amanatullah, MD and Mauro M. Giordani, MD.

CMS Open Payments shows 105 general payments to Dr. Nwankwo from 17 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 76% of the total. Medical Device Business Services, Inc. paid the most, $46,842.

Dr. Nwankwo graduated from University of California, San Francisco School of Medicine in 2013.

Dr. Nwankwo is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.